Trials / Terminated
TerminatedNCT02018172
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is performed to collect long-term data on the treatment adherence and patient's acceptability when Zomacton®10 mg is administered with the Zomajet® Vision X device in patients with a growth hormone deficiency or Turner's syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2013-12-23
- Last updated
- 2015-05-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02018172. Inclusion in this directory is not an endorsement.